vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Kontoor Brands, Inc. (KTB). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $853.2M, roughly 1.1× Kontoor Brands, Inc.). Kontoor Brands, Inc. runs the higher net margin — 4.3% vs 0.7%, a 3.6% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 27.3%). Kontoor Brands, Inc. produced more free cash flow last quarter ($55.8M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 14.2%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Kontoor Brands is an American clothing company. It was a spin off from the VF Corporation in May 2019, and markets clothing under the Lee, Wrangler and Helly Hansen brand names.
ASTH vs KTB — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $853.2M |
| Net Profit | $6.6M | $36.9M |
| Gross Margin | — | 41.3% |
| Operating Margin | 1.9% | 7.5% |
| Net Margin | 0.7% | 4.3% |
| Revenue YoY | 42.9% | 27.3% |
| Net Profit YoY | 184.4% | -47.6% |
| EPS (diluted) | $0.12 | $0.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $853.2M | ||
| Q2 25 | $654.8M | $658.3M | ||
| Q1 25 | $620.4M | $622.9M | ||
| Q4 24 | $665.2M | $699.3M | ||
| Q3 24 | $478.7M | $670.2M | ||
| Q2 24 | $486.3M | $606.9M | ||
| Q1 24 | $404.4M | $631.2M |
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $36.9M | ||
| Q2 25 | $9.4M | $73.9M | ||
| Q1 25 | $6.7M | $42.9M | ||
| Q4 24 | $-7.8M | $64.0M | ||
| Q3 24 | $16.1M | $70.5M | ||
| Q2 24 | $19.2M | $51.8M | ||
| Q1 24 | $14.8M | $59.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 41.3% | ||
| Q2 25 | — | 46.3% | ||
| Q1 25 | — | 47.5% | ||
| Q4 24 | — | 43.7% | ||
| Q3 24 | — | 44.7% | ||
| Q2 24 | — | 44.7% | ||
| Q1 24 | — | 45.2% |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | 7.5% | ||
| Q2 25 | 3.1% | 11.9% | ||
| Q1 25 | 3.3% | 11.8% | ||
| Q4 24 | 0.1% | 12.1% | ||
| Q3 24 | 5.9% | 14.7% | ||
| Q2 24 | 6.2% | 12.4% | ||
| Q1 24 | 7.5% | 13.4% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | 4.3% | ||
| Q2 25 | 1.4% | 11.2% | ||
| Q1 25 | 1.1% | 6.9% | ||
| Q4 24 | -1.2% | 9.1% | ||
| Q3 24 | 3.4% | 10.5% | ||
| Q2 24 | 3.9% | 8.5% | ||
| Q1 24 | 3.7% | 9.4% |
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | $0.66 | ||
| Q2 25 | $0.19 | $1.32 | ||
| Q1 25 | $0.14 | $0.76 | ||
| Q4 24 | $-0.14 | $1.13 | ||
| Q3 24 | $0.33 | $1.26 | ||
| Q2 24 | $0.40 | $0.92 | ||
| Q1 24 | $0.31 | $1.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $82.4M |
| Total DebtLower is stronger | — | $1.3B |
| Stockholders' EquityBook value | $779.3M | $529.6M |
| Total Assets | $2.2B | $2.9B |
| Debt / EquityLower = less leverage | — | 2.53× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | $82.4M | ||
| Q2 25 | $342.1M | $107.5M | ||
| Q1 25 | $260.9M | $356.7M | ||
| Q4 24 | $290.8M | $334.1M | ||
| Q3 24 | $350.3M | $269.4M | ||
| Q2 24 | $327.7M | $224.3M | ||
| Q1 24 | $337.3M | $215.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $735.6M | ||
| Q4 24 | — | $740.3M | ||
| Q3 24 | — | $745.0M | ||
| Q2 24 | — | $749.7M | ||
| Q1 24 | — | $779.2M |
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $529.6M | ||
| Q2 25 | $765.5M | $498.3M | ||
| Q1 25 | $745.4M | $426.7M | ||
| Q4 24 | $712.7M | $400.1M | ||
| Q3 24 | $704.6M | $356.9M | ||
| Q2 24 | $678.9M | $367.2M | ||
| Q1 24 | $653.5M | $387.2M |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $2.9B | ||
| Q2 25 | $1.4B | $2.7B | ||
| Q1 25 | $1.3B | $1.7B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.3B | $1.7B | ||
| Q2 24 | $1.3B | $1.6B | ||
| Q1 24 | $1.2B | $1.7B |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.53× | ||
| Q2 25 | — | 2.74× | ||
| Q1 25 | — | 1.72× | ||
| Q4 24 | — | 1.85× | ||
| Q3 24 | — | 2.09× | ||
| Q2 24 | — | 2.04× | ||
| Q1 24 | — | 2.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $64.1M |
| Free Cash FlowOCF − Capex | $-6.0M | $55.8M |
| FCF MarginFCF / Revenue | -0.6% | 6.5% |
| Capex IntensityCapex / Revenue | 0.3% | 1.0% |
| Cash ConversionOCF / Net Profit | -0.44× | 1.74× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $228.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $64.1M | ||
| Q2 25 | $90.9M | $25.7M | ||
| Q1 25 | $16.6M | $77.6M | ||
| Q4 24 | $-10.9M | $82.0M | ||
| Q3 24 | $34.0M | $133.6M | ||
| Q2 24 | $23.2M | $96.2M | ||
| Q1 24 | $6.0M | $56.5M |
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $55.8M | ||
| Q2 25 | $89.5M | $22.4M | ||
| Q1 25 | $13.6M | $74.9M | ||
| Q4 24 | $-13.5M | $75.0M | ||
| Q3 24 | $31.7M | $129.9M | ||
| Q2 24 | $20.4M | $92.6M | ||
| Q1 24 | $5.6M | $52.0M |
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | 6.5% | ||
| Q2 25 | 13.7% | 3.4% | ||
| Q1 25 | 2.2% | 12.0% | ||
| Q4 24 | -2.0% | 10.7% | ||
| Q3 24 | 6.6% | 19.4% | ||
| Q2 24 | 4.2% | 15.3% | ||
| Q1 24 | 1.4% | 8.2% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 1.0% | ||
| Q2 25 | 0.2% | 0.5% | ||
| Q1 25 | 0.5% | 0.4% | ||
| Q4 24 | 0.4% | 1.0% | ||
| Q3 24 | 0.5% | 0.6% | ||
| Q2 24 | 0.6% | 0.6% | ||
| Q1 24 | 0.1% | 0.7% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 1.74× | ||
| Q2 25 | 9.65× | 0.35× | ||
| Q1 25 | 2.48× | 1.81× | ||
| Q4 24 | — | 1.28× | ||
| Q3 24 | 2.11× | 1.89× | ||
| Q2 24 | 1.21× | 1.86× | ||
| Q1 24 | 0.40× | 0.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
KTB
| International Member | $292.0M | 34% |
| CTC Triangle B.V | $192.7M | 23% |
| Lee Segment | $186.7M | 22% |
| Helly Hansen Segment | $185.9M | 22% |
